The use of radiation therapy in cardiovascular medicine is a rapidly evolving field with ongoing research to refine techniques and explore new applications. In addition to preventing restenosis, cardiovascular radiation medicine is being investigated for its potential role in treating ventricular tachycardia, a life-threatening cardiac arrhythmia. The precise delivery of radiation to specific areas of the heart can target abnormal electrical pathways, disrupting the circuits responsible for arrhythmias. As with any medical intervention, safety considerations and long-term effects are important aspects of cardiovascular radiation medicine. Advancements in imaging technology, such as three-dimensional mapping systems and real-time imaging during radiation delivery, contribute to the precision and safety of these procedures. While still relatively novel, the integration of radiation therapy into cardiovascular medicine showcases the continuous exploration of innovative approaches to enhance patient outcomes and broaden the therapeutic options available for individuals with complex cardiovascular conditions.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India